Tekgunduz, E. Et Al. 2016. Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?. TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.1 , 30-34.

Tekgunduz, E., Kaya, A. H., CİVRİZ BOZDAĞ, S., Kocubaba, E., Kayikci, O., Namdaroglu, S., ... Ugur, B.(2016). Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?. TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.1, 30-34.

Tekgunduz, Emre Et Al. "Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?," TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.1, 30-34, 2016

Tekgunduz, Emre Et Al. "Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?." TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.1, pp.30-34, 2016

Tekgunduz, E. Et Al. (2016) . "Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?." TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.1, pp.30-34.

@article{article, author={Emre Tekgunduz Et Al. }, title={Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?}, journal={TRANSFUSION AND APHERESIS SCIENCE}, year=2016, pages={30-34} }